Below, we highlight three promising frameworks that provide valuable guidance and resources for assessing AI chatbots in ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...

Johnson & Johnson’s Abiomed has recalled automated controllers for its Impella heart pumps over a fault linked to three ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

Vivian Health reports AI is revolutionizing medical imaging, enhancing speed, accuracy, and patient care through advanced ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

Welcome an unexpected health nut to the top table: the GOP. The new laws might also help small food businesses.

The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Explore Mesoblast Limited's advancements in cell therapies, from FDA alignments to key trials. Click for MESO opportunities ...

The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exit ...